SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT FOR NON-US PARTICIPANTSStock Option Agreement • February 6th, 2020 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 6th, 2020 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (the “Agreement”) dated %%OPTION_DATE,’MM/DD/YYYY’%-% (“Grant Date”) between Seattle Genetics, Inc., a Delaware corporation (the “Company”), and %%FIRST_NAME%-% %%MIDDLE_NAME%-% %%LAST_NAME%-% (“Optionee”), is entered into as follows:
SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENTStock Option Agreement • February 6th, 2020 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 6th, 2020 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (the “Agreement”) dated %%OPTION_DATE,'MM/DD/YYYY'%-% (“Grant Date”) between Seattle Genetics, Inc., a Delaware corporation (the “Company”), and %%FIRST_NAME%-% %%MIDDLE_NAME%-% %%LAST_NAME%-% (“Optionee”), is entered into as follows:
COLLABORATION AGREEMENTCollaboration Agreement • February 6th, 2020 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 6th, 2020 Company Industry Jurisdiction[ *** ] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
ELEVENTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • February 6th, 2020 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 6th, 2020 Company IndustryEffective as of the date of the last signature below, AbbVie Inc. (the successor-in-interest to Abbott Laboratories), a Delaware corporation having a principal place of business at 1 N Waukegan Road, North Chicago, IL 60064 (“AbbVie”), and Seattle Genetics, Inc., a Delaware corporation having a principal place of business at 21823 – 30th Drive Southeast in Bothell, Washington 98021 (“Seattle Genetics”) (individually the “Party” or collectively the “Parties”) agree to the following terms and conditions as set forth below (this “Eleventh Amendment”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Agreement (as defined below).